.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
MASAI RCT: 12% reduction in interval cancer rate using Transpara
%20(1).png)
MASAI RCT: 12% reduction in interval cancer rate using Transpara
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
.png)
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
Ikonopedia Enhances Breast Cancer Detection with Integrated AI Technology from ScreenPoint Medical
.png)
Ikonopedia Enhances Breast Cancer Detection with Integrated AI Technology from ScreenPoint Medical
New Transpara integration provides radiologists with automated insights for more accurate and productive patient diagnoses and care.
June 14, 2025
Podcast: ScreenPoint Co-Founder Talks Future of Breast Cancer Screening
.png)
Podcast: ScreenPoint Co-Founder Talks Future of Breast Cancer Screening
Nico Karssemeijer, Chief Science Officer and Co-Founder of ScreenPoint Medical, joins Impact AI podcast to discuss how his team is revolutionizing breast cancer screening through cutting-edge AI.
June 10, 2025
ScreenPoint Medical Showcases Transpara® Breast AI Designed to Improve Cancer Detection and Support Single Reader Screening at ECR
.png)
ScreenPoint Medical Showcases Transpara® Breast AI Designed to Improve Cancer Detection and Support Single Reader Screening at ECR
AI-Supported Screening Delivering Real-World Clinical Results in Research Studies being Presented at ECR
February 21, 2024